We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

3D cell Culture Firm Reinnervate and Specialist Oncology CRO Oncotest GmbH Enter Collaboration Agreement

News   Jan 07, 2013

 
3D cell Culture Firm Reinnervate and Specialist Oncology CRO Oncotest GmbH Enter Collaboration Agreement
 
 
 

RELATED ARTICLES

Nanotechnology Approach for Treating Aggressive Breast Cancer

News

Triple negative breast cancer has no currently approved targeted therapies for treatment. Utilizing nanotechnology, a research group have developed a method that targets specific genes in triple negative breast cancer, killing cancerous cells.

READ MORE

Tissue-engineering Approach for Common Jaw Defect

News

Cells were taken from the rib cartilage of a Yucatan miniature pig, grown in a laboratory and implanted as a construct into a separate animal.

READ MORE

Protein Switches Sides in Leukemia

News

Researchers have discovered that an epigenetic protein called EZH2 delays the development of acute myeloid leukemia (AML) but then switches sides once the disease is established to help maintain tumor growth.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE